Table 2.
Correlation between serum IL-32 concentration and pulmonary function in patients with stable COPD (N = 116).
| Items | Correlation analysis | ||
|---|---|---|---|
| IL-32 and FEV1/FVC | IL-32 and FEV1% predicted | ||
| Pearson correlation | Correlation coefficient | − 0.356 | − 0.300 |
| p value | 0.001 | 0.001 | |
| Model summary | Correlation coefficient | 0.356 | 0.300 |
| R square | 0.093 | 0.097 | |
| Adjusted R square | 0.082 | 0.086 | |
| SE of the estimate | 0.134 | 0.177 | |
| Analysis of variance | Mean square | 0.203 | 0.355 |
| F value | 11.207 | 11.295 | |
| p value | 0.001 | 0.001 | |
| Regression coefficient | Regression coefficients | 0.593 | 0.634 |
| SE | 0.042 | 0.056 | |
| T value | − 3.348 | − 3.361 | |
| p value | 0.001 | 0.001 | |
| 95% confidence interval | − 0.002% to − 0.000% | − 0.001% to − 0.000% | |
| Equation | ^Y = 0.593–0.096X | ^Y = 0.634–0.062X | |
IL-32 interleukin-32, FEV1 the value of forced expiratory volume in one second, FVC forced vital capacity.